# APREPITANT
> **ANDA216976** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMACEUTICALS INC · Approved 2025-11-17
## Drug
- **FDA Application Number:** ANDA216976
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APREPITANT
- **Generic name:** Aprepitant
- **Active ingredients:** APREPITANT
- **Dosage form:** INJECTION, EMULSION
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN PHARMACEUTICALS INC
- **First approval:** 2025-11-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216976)
---
*MORVS · CC0 1.0*